Androgel Testosterone MDL
Lawsuits against AbbieVie, Inc. – the maker of Androgel – and four other pharmaceutical companies making testosterone replacement therapy drugs have been centralized into a multi district litigation court (MDL) in Illinois. Some 3,500
Testosterone Label Change required by FDA
A testosterone label change has been required by the FDA. In a March 3, 2015 safety announcement, the agency said that it was requiring the label change to inform users of a possible increased
FDA calls for Testosterone Label Change
An FDA Drug Safety Communication on March 3, 2014 cautioned that testosterone products used for low testosterone due to aging require a labeling change regarding possible increased risks of heart attacks and strokes. The
FDA says Low T Products must carry Blood Clot Warning
The U.S. Food and Drug Administration (FDA) announced on June 20, 2014 that Low T Products must carry blood clot warning information. The agency announcement said Low T products must now warn on the
Testosterone Lawsuit filed in Philadelphia
Matthews & Associates filed a Testosterone Lawsuit in Philadelphia today before the Philadelphia Court of Common Pleas. The defendant is Auxilium Pharmaceuticals, Inc., the maker of Testim, the testosterone gel product named in the
Generic Low T Injustice from Supreme Court
The FDA has the power to fix the ongoing injustice of those hurt by generic drugs left out in the cold by five corporate-friendly judges who sit on the Supreme Court, yet the agency
JAMA attacked by Testosterone Money
Like mountain goats locking horns to determine supremacy, testosterone battles are raging between researchers not beholden to Big Pharma and researchers who are. The Wall Street Journal reported yesterday that researchers paid by companies
Androgel Pay to Delay Lawsuit allowed by Supreme Court
Supreme Court: FTC can challenge Pay to Delay Schemes An Androgel pay to delay lawsuit was at the center of a Supreme Court case decided last summer which could eventually affect many other drug
Abbott Androgel Lawsuit
An Abbott Androgel Lawsuit was filed this week in federal court by Stephen Benn against Abbott Laboratories and Abbvie, the makers and distributors of Androgel. The companies advertised to convince millions of men that
Testosterone Lawsuit in Supreme Court
A Testosterone Lawsuit in Supreme Court is the subject of a pay to delay case. In March 2013 the U.S. Supreme Court heard a case that concerns most Americans and most of Big Pharma.
Testosterone raises Heart Attack Risk
The journal PLOS ONE published a study this week that links testosterone therapy in men over 65 to a doubled increased risk of heart attacks. Therapy with testosterone raises heart attack risk, triples the